In 2015, a Cognitive Vitality Report released by the Alzheimers Drug Discovery Foundation stated that two multi-year treatment trials had found that epithalamin, from which epitalon is isolated, had imparted no severe adverse events in older adults, and that preclinical trials supported a favorable safety profile.35 Ten years later, a systematic review published in 2025 stated that information regarding critical issues about this peptides safety is missing.1 In terms of human trials, the best case we have in support of epitalons safety is a 2002 trial involving 162 patients in which no one in the epitalon group reported serious side effects.36 At the same time, the U.S
Do not use a product with a broken seal
BPC-157 remains an experimental compound without regulatory approval for human use
aureus , the BSH levels are lower (0.31 mM) in the different clinical isolates (COL, USA300, Mu50, or N315) and BSH levels are not up-regulated during the stationary phase (Posada et al., 2014)
CJC-1295 (no DAC) is a 29-residue GHRH(1-29) analog carrying stabilizing substitutions, including a D-Ala at position 2 that confers resistance to DPP-IV cleavage
Phytobiomes J, 2023
